Low hgb
Pro Research Analysisby 
Searched over 200M research papers for "low hgb"
Understanding Low Hemoglobin (Hgb) Levels: Implications and Management
Low Hemoglobin in Hemodialysis Patients
Anemia at Hemodialysis Initiation
Anemia is a common issue among patients initiating hemodialysis (HD). Research indicates that low hemoglobin (Hgb) levels at the start of HD are associated with increased mortality within the first year of treatment. Patients with Hgb levels below 10 g/dL at the beginning of HD often require higher doses of erythropoiesis-stimulating agents (ESAs) but not intravenous (IV) iron during the initial three months of HD1. This suggests that proactive anemia management in advanced chronic kidney disease (CKD) could potentially improve survival rates for HD patients.
Iron Status Markers in Children with CKD
In children with CKD, iron status markers such as serum ferritin and transferrin saturation (TSAT) are used to assess the risk of low Hgb levels. Studies show that lower glomerular filtration rate (GFR), serum iron below 50 µg/dL, and ferritin levels above 100 ng/mL are strongly associated with lower Hgb percentiles2. This highlights the importance of monitoring iron levels to manage anemia effectively in pediatric CKD patients.
Hemoglobin and Cardiovascular Outcomes
Women with Suspected Ischemia
Low Hgb levels are linked to adverse cardiovascular outcomes in women undergoing evaluation for chest pain. Anemic women (Hgb <12 g/dL) have a higher risk of death and adverse cardiovascular events compared to non-anemic women. This association persists even after adjusting for other cardiovascular risk factors, indicating that low Hgb is an independent predictor of poor cardiovascular outcomes3.
Head and Neck Cancer Patients
In patients with head and neck cancer undergoing radiation therapy, low Hgb levels are associated with poor locoregional disease control and survival. Anemia in these patients may contribute to intratumoral hypoxia, leading to radioresistance. Correcting anemia could potentially improve treatment outcomes, although the optimal Hgb threshold for this population remains unclear7.
Quality of Life and Anemia Management
Epoetin Alfa in Chronic Conditions
Epoetin alfa has been shown to improve Hgb levels and health-related quality of life (HRQL) in patients with anemia due to cancer, HIV/AIDS, and CKD. Clinical trials indicate significant improvements in Hgb and reductions in fatigue, enhancing overall quality of life for these patients4.
Iron Supplementation in Infants
In low-income infants with low Hgb levels, additional iron supplementation does not significantly enhance Hgb values if they are already consuming iron-fortified formulas. This suggests that routine screening and treatment for low Hgb in healthy infants may not be necessary6.
Innovative Approaches to Hemoglobin Monitoring
Point-of-Care Anemia Testing
A novel point-of-care (POC) test for anemia allows for rapid, visual, and color-based Hgb level estimation using a single drop of blood. This test correlates well with traditional hematology analyzer results and offers a cost-effective solution for anemia screening and self-monitoring5.
Remote Monitoring for Sickle Cell Disease
For patients with sickle cell disease (SCD), noninvasive remote monitoring of Hgb levels using hyperspectral color truthing and machine learning shows promise. This method provides accurate Hgb readings from digital photos of the inner eyelid, potentially reducing the need for frequent invasive blood draws and improving disease management10.
Maternal Hemoglobin and Birth Outcomes
U-Shaped Association with Low Birth Weight
In rural Bangladesh, both very low and high maternal Hgb levels are associated with an increased risk of low birth weight (LBW). This U-shaped relationship suggests that both anemia and high Hgb levels during pregnancy can adversely affect birth outcomes, emphasizing the need for balanced iron supplementation9.
Conclusion
Low hemoglobin levels have significant implications across various patient populations, from those undergoing hemodialysis to children with CKD, women with cardiovascular concerns, and cancer patients. Effective management of anemia, whether through proactive treatment, iron supplementation, or innovative monitoring techniques, is crucial for improving patient outcomes and quality of life. Further research is needed to refine these strategies and optimize care for individuals with low Hgb levels.
Sources and full results
Most relevant research papers on this topic
Low hemoglobin at hemodialysis initiation: an international study of anemia management and mortality in the early dialysis period
Anemia at hemodialysis initiation is common and associated with elevated mortality, suggesting a proactive approach to anemia management in advanced chronic kidney disease may improve survival on dialysis.
Observational Study
Rigorous JournalAssociation between common iron store markers and hemoglobin in children with chronic kidney disease
Higher serum ferritin and lower hemoglobin levels in children with chronic kidney disease indicate iron-restricted erythropoiesis.
Observational StudyHemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain: results from the National Heart, Lung, and Blood Institute Women's Ischemia Syndrome Evaluation Study.
Lower hemoglobin levels are associated with a higher risk of adverse cardiovascular outcomes in women undergoing evaluation for suspected ischemia in the absence of acute MI or CHF.
Observational Study
Highly CitedDoes epoetin alfa improve health-related quality of life in chronically ill patients with anemia? Summary of trials of cancer, HIV/AIDS, and chronic kidney disease.
Epoetin alfa significantly improves health-related quality of life in patients with anemia caused by cancer, HIV/AIDS, and chronic kidney disease, particularly reducing fatigue.
Systematic ReviewDisposable platform provides visual and color-based point-of-care anemia self-testing.
This disposable, point-of-care anemia test provides a reliable, and cost-effective method for self-screening and self-monitoring of anemia, with comparable sensitivity and specificity to hematology analyzers.
Observational StudyRigorous JournalRandomized, placebo-controlled trial of iron supplementation in infants with low hemoglobin levels fed iron-fortified formula.
Additional iron supplementation in low-income infants with low hemoglobin levels fed iron-fortified formulas does not enhance Hgb values, and screening healthy infants fed iron-fortified formula at 6 months is not justified.
RCT
Large Human TrialImpact of anemia in patients with head and neck cancer treated with radiation therapy
Correcting anemia before or during radiation therapy may improve local control and survival in head and neck cancer patients.
Association of bone mineral density with hemoglobin and change in hemoglobin among older men and women: The Cardiovascular Health Study.
Decreasing hemoglobin levels are not significantly associated with bone mineral density in older men and women.
Observational StudyRigorous JournalU-Shaped Association between Maternal Hemoglobin and Low Birth Weight in Rural Bangladesh
Maternal hemoglobin levels have a U-shaped relationship with low birth weight risk in rural Bangladesh, with the highest risk at very low and high levels.
Observational StudyRigorous Journal